Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Clonal structure and the specificity of vaccine-induced T cell response to SARS-CoV-2 Spike protein.

  • Authors : Sheetikov SA; Laboratory of Transplantation Immunology, National Medical Research Center for Hematology, Moscow, Russia.; Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines* ; Communicable Diseases*

  • Source: Frontiers in immunology [Front Immunol] 2024 Apr 02; Vol. 15, pp. 1369436. Date of Electronic Publication: 2024 Apr 02 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection

Record details

×
Academic Journal

The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies.

Subjects: Immunoglobulin G* ; Vaccines*; Humans

  • Source: Frontiers in immunology [Front Immunol] 2024 Feb 16; Vol. 15, pp. 1325387. Date of Electronic Publication: 2024 Feb 16 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection

Record details

×
Academic Journal

Safety monitoring in inactivated COVID-19 vaccines by clinical pharmacists from a single center in China.

  • Authors : Hu M; Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, China.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; COVID-19 Vaccines/COVID-19 Vaccines/COVID-19 Vaccines/adverse effects

  • Source: Frontiers in immunology [Front Immunol] 2022 Sep 05; Vol. 13, pp. 882919. Date of Electronic Publication: 2022 Sep 05 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection

Record details

×

Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review.

  • Authors : Boroumand AB; Department of Emergency Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.; Forouhi M

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Diabetes Mellitus, Type 2* ; Vaccines*

  • Source: Frontiers in immunology [Front Immunol] 2022 Aug 29; Vol. 13, pp. 940357. Date of Electronic Publication: 2022 Aug 29 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection

Record details

×
Academic Journal

Role of COVID-19 Vaccines in SARS-CoV-2 Variants.

  • Authors : Zhou Z; Department of Immunology, School of Basic Medical Sciences, Peking University, NHC Key Laboratory of Medical Immunology (Peking University), Beijing, China.; Department of Clinical Pharmacology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; 2019-nCoV Vaccine mRNA-1273 SARS-CoV-2 variants

  • Source: Frontiers in immunology [Front Immunol] 2022 May 20; Vol. 13, pp. 898192. Date of Electronic Publication: 2022 May 20 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection

Record details

×
Academic Journal

Evaluation of the humoral and mucosal immune response of a multiepitope vaccine against COVID-19 in pigs.

  • Authors : Mosqueda J; Immunology and Vaccines Laboratory, Facultad de Ciencias Naturales, Universidad Autonoma de Queretaro, Carretera a Chichimequillas, Santiago de Querétaro, Querétaro, Mexico.; Hernández-Silva DJ

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Swine

  • Source: Frontiers in immunology [Front Immunol] 2023 Dec 20; Vol. 14, pp. 1276950. Date of Electronic Publication: 2023 Dec 20 (Print Publication: 2023).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection

Record details

×
Academic Journal

Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates.

  • Authors : Pérez P; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Mice SARS-CoV-2 variants

  • Source: Frontiers in immunology [Front Immunol] 2023 Dec 12; Vol. 14, pp. 1264323. Date of Electronic Publication: 2023 Dec 12 (Print Publication: 2023).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection

Record details

×
Academic Journal

Analysis of vaccine responses after anti-CD20 maintenance in B-cell lymphoma in the Balearic Islands. A single reference center experience.

  • Authors : Gutierrez A; Service of Hematology, University Hospital Son Espases/Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.; Alonso A

Subjects: Agammaglobulinemia* ; Vaccines* ; COVID-19*

  • Source: Frontiers in immunology [Front Immunol] 2023 Nov 01; Vol. 14, pp. 1267485. Date of Electronic Publication: 2023 Nov 01 (Print Publication: 2023).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection

Record details

×
Academic Journal

Longitudinal evaluation of innate immune responses to three doses of CoronaVac vaccine.

  • Authors : Cao C; Department of Laboratory Medicine, Jiangnan University Medical Center, Wuxi, Jiangsu, China.; Department of Laboratory Medicine, Changzhou Jintan First People's Hospital, Changzhou, Jiangsu, China.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Humans

  • Source: Frontiers in immunology [Front Immunol] 2023 Oct 02; Vol. 14, pp. 1277831. Date of Electronic Publication: 2023 Oct 02 (Print Publication: 2023).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection

Record details

×
Academic Journal

SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients.

  • Authors : Smetanova J; Department of Immunology, Second Faculty of Medicine Charles University and Motol University Hospital, Prague, Czechia.; Milota T

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; Myositis Ossificans*

  • Source: Frontiers in immunology [Front Immunol] 2022 Nov 09; Vol. 13, pp. 1017232. Date of Electronic Publication: 2022 Nov 09 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection

Record details

×
  • 1-10 of  38 results for ""COVID-19 vaccines""